Construction and diagnosis and treatment application of GSH (glutathione) activated / induced aggregation ultra-small long afterglow probe PLNP-pep-coated Cu2 + / RAW
The ultra-small long afterglow nanomaterials were prepared by one-step amino method and the GSH activation probe was constructed, which solved the problems of complex postmodification and non-targeted aggregation, realized tumor microenvironment-specific imaging and chemodynamic therapy, and improved imaging and treatment effects .
Patent Information
- Application Number
- CN202411054266.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-02
- Publication Date
- 2024-12-03
AI Technical Summary
The postmodification process of existing long afterglow nanomaterials is complex, resulting in increased particle size, reduced optical performance, reduced imaging signal-to-noise ratio, and the larger particle size is non-targeted aggregation in endothelial reticular systems such as the liver, lacking specificity. It is prone to false positive results, and ultra-small nanoparticles metabolize fast but have a short residence time, which is not conducive to biological imaging.
Ultra-small-sized long afterglow nanomaterials were prepared by one-step amino method, and GSH activation/induced aggregation of ultra-small-small-long afterglow probes were constructed through modification of TAT/PD-L1 and Cu2+, realizing tumor microenvironment-specific imaging and chemodynamic therapy.
The post-modification process is simplified, the metabolic time of nanoparticles is improved, non-targeted aggregation is avoided, and accurate imaging and chemical dynamic therapeutic effects of tumor sites are achieved, enhancing imaging and therapeutic effects.
Smart Images

Figure CN119060720A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the controllable preparation of an amino-functionalized small-size long-afterglow luminescent nanomaterial and its application in tumor microenvironment-specific imaging, belonging to the field of advanced functional materials and biomedicine technology. Background Art
[0002] Cancer, one of the world's most common diseases, poses a serious threat to human health and social development. Developing highly specific and sensitive tumor diagnostic methods and implementing effective treatments based on them is key to improving the survival rate of cancer patients. The occurrence and progression of cancer are often accompanied by abnormal microenvironmental changes, such as enzyme overexpression, decreased pH, and imbalanced redox levels. Glutathione (GSH), a thiol essential for regulating life activities, is present in tumors at concentrations up to 1,000 times that of normal tissues. This characteristic provides new research directions and strategies for the diagnosis and treatment of cancer.
[0003] Integrated diagnosis and treatment can track the occurrence, development and treatment process of tumors in real time, and has attracted much attention compared to simple diagnosis and treatment. Treatment guided by optical imaging can achieve real-time monitoring of tumors. However, traditional optical probes are mainly based on organic fluorescent probes or inorganic fluorescent probes, which require continuous in-situ excitation, have serious background fluorescence interference, severe light scattering, and long-term excitation can cause thermal damage to tissues. In contrast, long-lasting nanoparticles (PLNPs) have the advantages of long-term free in-situ excitation and no background fluorescence interference. They can make up for many of the shortcomings of traditional optical probes and show good application prospects in the direction of diagnosis and treatment.
[0004] However, the post-modification process for existing long-lasting fluorescence-based probes is complex, often requiring two or more reaction steps to achieve functional group modification. This process increases the particle size of the material and reduces the optical properties of the PLNP, compromising imaging quality. Imaging systems exhibit a constant luminescence signal at both lesions and normal tissues, which can easily lead to false-positive signals. Furthermore, non-targeted aggregation of larger nanoparticles in the endothelial reticular system, such as the liver and kidneys, is unavoidable. Although ultrasmall nanoparticles have rapid metabolism and a short circulation half-life, their short residence time at lesions hinders bioimaging.
[0005] The present invention synthesizes ultrasmall long-afterglow nanomaterials through a one-step amino method, and further constructs a tumor microenvironment responsive probe. Summary of the Invention
[0006] Technical issues: On the one hand, the post-modification process of long-lasting fluorescence is complex, requiring multiple reactions to modify surface functional groups. This process is often accompanied by an increase in particle size and a loss of optical performance, resulting in a decrease in the imaging signal-to-noise ratio. On the other hand, larger particles accumulate in non-targeted areas of the endothelial reticular system, such as the liver, and their signals remain consistent in normal tissue and lesions, lacking specificity and prone to false-positive results. Although ultra-small long-lasting fluorescence nanoparticles have rapid metabolism and a short circulation half-life, their short residence time in lesions is not conducive to biological imaging.
[0007] Technical solution: To solve the above problems, the present invention provides a one-step controllable preparation method of amino-functionalized ultrasmall long-afterglow luminescent nanomaterials, and uses it for intelligent imaging of tumor microenvironment response. It overcomes and solves the problems of traditional long-afterglow nanomaterials such as complex post-modification process, lack of responsiveness to lesions, and nonspecific aggregation in normal tissues and organs.
[0008] The first object of the present invention is a one-step amino method for preparing ultra-small-sized long-lasting nanoparticles, comprising the following steps:
[0009] S11. Heat and dissolve Zn(acac)2·xH2O, Ga(acac)3, and Cr(acac)3 solids in a mixed solution of octadecene and oleic acid, cool the mixture to 40-50°C, add methanol and ethylenediamine, and keep stirring to obtain a mixed solution; transfer the mixed solution to a high-pressure reactor for a solvent thermal reaction. After the reaction is completed, cool the mixture, add ethanol to precipitate the product, separate the solid and liquid, collect the solid, wash, and dry to obtain an ultra-small-sized long-afterglow nanoparticle (ZnGa2O4:Cr-NH2) PLNP-NH2 solid powder.
[0010] Furthermore, in step S11, in the mixed solution formed by octadecene and oleic acid, the volume ratio of octadecene to oleic acid is 5:2-5:3;
[0011] Furthermore, in step S11, the volume ratio of ethylenediamine to oleic acid is 1:1-1:3;
[0012] In some embodiments of the present invention, in step S11, the molar ratio of Zn(acac)2·xH2O, Ga(acac)3, and Cr(acac)3 is 1:2:0.001-1:2:0.008;
[0013] In some preferred embodiments, in step S11, the molar ratio of Zn(acac)2·xH2O, Ga(acac)3, and Cr(acac)3 is 1:2:0.004;
[0014] In some embodiments, the concentration of Zn(acac)2·xH2O in the mixed system is 0.005-0.05mmolmL -1 .
[0015] Furthermore, in step S11, the amount of methanol added is 5%-20% of the total volume;
[0016] Furthermore, in step S11, the solvent thermal reaction is carried out at 180-250° C. for 24-72 hours.
[0017] In one embodiment of the present invention, step S11: Zn(acac)2·xH2O, Ga(acac)3, and Cr(acac)3 solids are dissolved in a mixed solution of octadecene and oleic acid under stirring at 80°C, and after the mixture is free of solid particles, the mixture is cooled to 40-50°C, methanol and ethylenediamine are added, and stirring is maintained to obtain a mixed solution; the final mixed solution is transferred to a stainless steel autoclave lined with Teflon, and solvent thermally reacted at 220°C for 24 hours, the product is naturally cooled to room temperature, anhydrous ethanol is added to precipitate the product, and the product is centrifuged at a high speed of 8000-10000 rpm using a centrifuge, the supernatant is discarded, and the mixture is washed three times with a mixed solution of anhydrous ethanol and cyclohexane, and vacuum dried to obtain white ultra-small-sized long-afterglow nanoparticles (ZnGa2O4:Cr-NH2, PLNP-NH2);
[0018] The second object of the present invention is to provide a GSH activation / induced aggregation ultra-small long afterglow probe PLNP-pep@Cu based on the ultra-small size long afterglow nanoparticles PLNP-NH2 2+ / RAW method, comprising the steps of: preparation of ultra-small PLNP-NH2 and modification of TAT / PD-L1, Cu 2+ Modification of RAW and modification of RAW; the details are as follows;
[0019] S12. Modification of TAT / PD-L1 polypeptide chain: ultrasonically disperse the PLNP-NH2 solid powder obtained in step S11 in DMF, add anhydrous K2CO3, then add bromoacetyl bromide, stir and react in a sealed state, wash after the reaction, and dry to obtain solid powder PLNP-Br; disperse PLNP-Br in DMF, add anhydrous K2CO3, then add TAT / PD-L1 polypeptide, stir and react, wash and dry after the reaction to obtain PLNP-pep;
[0020] S13、Cu 2+ Modification: The PLNP-pep solid prepared in step S12 was ultrasonically dispersed in anhydrous methanol and Cu 2+, shake and react at room temperature, and wash to obtain PLNP-pep@Cu 2+ ;
[0021] S14. Targeted modification of cell membrane RAW: LPS was added to the DMEM solution containing macrophages for polarization; the polarized M1 macrophages were mixed with PLNP-pep@Cu 2+ The PLNP-pep@Cu nanoparticles were dispersed in PBS and incubated with ultrasound. After continuous extrusion through the filter membrane using a micro extruder, the nanoparticles were removed to obtain the loaded material. 2+ / RAW.
[0022] In some embodiments of the present invention, in step S12, the concentration of PLNP-NH2 is 1-2 mg mL -1 ;
[0023] Furthermore, in step S12, the amount of K2CO3 used is based on ensuring that the reaction system becomes alkaline;
[0024] In some embodiments of the present invention, in step S12, the concentration of PLNP-Br is 1-2 mg mL -1 ;
[0025] Furthermore, in step S12, the TAT / PD-L1 polypeptide sequence is: RKKRRQRRRC&CVRARTR.
[0026] In some embodiments of the present invention, in step S13, the concentration of PLNP-pep is 1-2 mg mL -1 ;
[0027] In some embodiments of the present invention, in step S13, the amount of CuCl2·2H2O is 1.7-3.4 mg mL -1 ;
[0028] Furthermore, in step S14, the concentration of macrophages in the solution is not less than 10 5 / mL;
[0029] In some embodiments of the present invention, in step S14, the number of extrusions is not less than 10 times.
[0030] In some embodiments of the present invention, the reaction time of step S12 is 6-16 hours;
[0031] In some embodiments of the present invention, step S12 washing step uses ethanol and purified water to wash alternately 4-6 times;
[0032] In some embodiments of the present invention, step S13, Cu 2+Modification: The PLNP-pep solid obtained in step S12 was ultrasonically dispersed in anhydrous methanol, and CuCl2·2H2O was added and shaken at room temperature for 4 hours; after the reaction, it was washed with ultrapure water 1-3 times to obtain PLNP-pep@Cu 2+ ;
[0033] In some embodiments of the present invention, step S14 targets the modification of cell membrane RAW: LPS is added to the DMEM solution containing macrophages for polarization, and the solution is changed every 12-24 hours for a total of 72 hours; then the polarized M1 macrophages are mixed with PLNP-pep@Cu 2+ The nanoparticles were dispersed together in PBS and incubated with ultrasound for 30 min. After continuous extrusion through a 1 μm polycarbonate filter membrane using a micro extruder, the individual nanomaterials were removed by centrifugation to obtain the PLNP-pep@Cu loaded material. 2+ / RAW.
[0034] In some embodiments of the present invention, in step S12, the drying method is freeze drying;
[0035] In some embodiments of the present invention, in step S14, the amount of LPS is 20 μL LPS, and the concentration is 1 mg mL -1 ;
[0036] In some embodiments of the present invention, in step S14, the PLNP-pep@Cu 2+ Concentration 1 mg mL -1 ;
[0037] In some embodiments, the filter membrane in step S14 is a carbonate filter membrane; preferably a 1 μm polycarbonate filter membrane;
[0038] The present invention is a method for constructing a tumor microenvironment responsive probe based on the above-mentioned ultrasmall long-afterglow nanoparticles; the steps are as follows:
[0039] The third object of the present invention is to provide a GSH activation / induced aggregation ultra-small long-lasting probe obtained by the construction method.
[0040] The GSH activation / induced aggregation ultra-small long afterglow probe PLNP-pep@Cu based on ultra-small size long afterglow nanoparticles PLNP-NH2 provided by the present invention 2+ / RAW, which not only enables tumor microenvironment-specific imaging but also has excellent chemodynamic therapeutic effects.
[0041] The fourth object of the present invention is to provide the use of the GSH-activated / induced aggregation ultrasmall long-lasting probe in biological imaging preparations or the preparation of anti-tumor drugs.
[0042] Beneficial effects of the present invention:
[0043] (1) The present invention adopts a one-step amino method to prepare long-lasting nanomaterials, which effectively simplifies the post-modification process. The particle size is only 5-10nm, which effectively increases the metabolic time in the body and avoids its accumulation in the endothelial reticular system such as the liver;
[0044] (2) The present invention is based on the tumor microenvironment response probe PLNP-pep@Cu prepared from the above-mentioned long afterglow nanomaterials 2+ / RAW, quenching the long-lasting red phosphorescence, and when it reaches the tumor site, the overexpressed GSH converts Cu 2+ Reduction to Cu + , so that the red phosphorescence of the probe is restored and precise imaging is achieved;
[0045] (3) PLNP-pep@Cu prepared by the present invention 2+ / RAW undergoes self-aggregation, the particle size increases, and the retention time at the lesion site increases, achieving better imaging effects;
[0046] (4) PLNP-pep@Cu prepared by the present invention 2+ When RAW reaches the tumor site, the released Cu + It can be used as a chemical dynamic catalyst to catalyze the conversion of endogenous H2O2 into ·OH, thus exerting a chemical dynamic therapeutic effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0047] Figure 1 : TEM of PLNP-NH2 prepared in Example 1 (Figure a) and Example 2 (Figure b) (scale bar is 50 nm);
[0048] Figure 2 : Phosphorescence emission spectra of PLNP-NH2 prepared in Examples 1 and 2;
[0049] Figure 3 : Afterglow decay graphs of PLNP-NH2 prepared in Example 1 (Figure a) and Example 2 (Figure b);
[0050] Figure 4 : FT-IR of PLNP-NH2 prepared in Examples 1 and 2;
[0051] Figure 5 : PLNP-pep@Cu with different extrusion times prepared in Example 3 2+ / TEM of RAW (scale bar is 50 nm);
[0052] Figure 6 : After adding different amounts of GSH, PLNP-pep@Cu 2+ The phosphorescence intensity;
[0053] Figure 7 : PLNP-pep@Cu prepared in Example 3 2+ TEM image after reaction with GSH (scale bar is 50 nm);
[0054] Figure 8 : PLNP-pep@Cu prepared in Example 3 2+ Hydration particle size diagram after reaction with GSH;
[0055] Figure 9 : PLNP-pep@Cu prepared in Example 3 2+ UV absorption after reaction with MB;
[0056] Figure 10 :PLNP-TAT, PLNP-pep and PLNP-pep@Cu 2+ CLSM images of RAW and 3T3 cells cultured at different times (scale: 30 μm)
[0057] Figure 11 :PLNP-TAT, PLNP-pep and PLNP-pep@Cu 2+ / CLSM images of RAW and SCC-7 cells cultured at different times (scale bar: 30 μm);
[0058] Figure 12 : Survival rate of SCC-7 cells in different treatment groups;
[0059] Figure 13 :SCC-7 cell staining imaging in different treatment groups;
[0060] Figure 14 : Indicative diagram of ·OH production in SCC-7 cells under different treatment groups (scale bar: 20 μm). DETAILED DESCRIPTION
[0061] The following describes preferred embodiments of the present invention. It should be understood that the embodiments are for better explanation of the present invention and are not intended to limit the present invention.
[0062] Example 1:
[0063] A one-step preparation method for amino-functionalized ultra-small long-lasting nanomaterials is prepared by acetylacetone solvothermal method, and the steps are as follows:
[0064] (1) Zn(acac)2·xH2O, Ga(acac)3, and Cr(acac)3 solids were dissolved in a mixed solution of octadecene and oleic acid at 80°C with stirring until the mixture was free of solid particles. The mixture was cooled to 40-50°C, methanol and ethylenediamine were added, and stirring was continued to obtain a mixed solution. The concentration of Zn(acac)2·xH2O in the mixed solution relative to the mixed system was 0.01 mmol mL -1 The molar ratio of the Zn(acac)2·xH2O, Ga(acac)3, and Cr(acac)3 solids is 1:2:0.004; the volume of methanol is 10% of the total volume; the volume ratio of octadecene, oleic acid, and ethylenediamine is 50:30:10; 50 mL of octadecene;
[0065] (2) transferring the mixed solution obtained in step (1) to a stainless steel autoclave lined with Teflon and subjecting it to a hydrothermal reaction at 220° C. for 24 hours;
[0066] (3) The product obtained in step (2) was naturally cooled to room temperature, anhydrous ethanol was added to precipitate the product, and high-speed centrifugation was performed at 8000-10000 rpm. The supernatant was discarded, and the precipitate was washed 3-4 times with a mixed solution of cyclohexane and anhydrous ethanol;
[0067] (4) drying the product obtained in step (3) in a vacuum oven at 30-40° C. to obtain an ultra-small long-lasting-glow nanomaterial with an amino group;
[0068] The results are as follows Figure 1 、 2 As shown in , 3, and 4, the particle size of the prepared long afterglow nanomaterial is only 9.53±2.11nm, and the optical properties are good. FT-IR shows that the -1 A double peak of amino group appeared.
[0069] Example 2:
[0070] A one-step preparation method for amino-functionalized ultra-small long afterglow nanomaterials is prepared by an acetylacetone solvent thermal method. The steps and method are basically the same as those in Example 1, except that: the composition of the solvent in step (1) is changed: Zn(acac)2·xH2O, Ga(acac)3, and Cr(acac)3 solids are dissolved in a mixed solution of octadecene and oleic acid under stirring at 80°C until the mixture contains no solid particles; the mixture is cooled to 40-50°C, methanol and ethylenediamine are added, and stirring is maintained to obtain a mixed solution; the volume ratio of octadecene, oleic acid, and ethylenediamine is 50:20:20;
[0071] The long afterglow luminescent nanoparticles prepared in this embodiment were tested and the results were as follows: Figure 1-4As shown in the figure: the emission light of the long afterglow nanoparticles prepared by this method is weaker than that of the long afterglow prepared in Example 1. At the same time, the FT-IR at 3330 cm -1 The peak of is significantly lower, indicating that long afterglow nanoparticles can be successfully prepared under this condition, but the amount of amino groups on the surface is less than that of the long afterglow nanoparticles prepared in Example 1.
[0072] Example 3: Construction of a tumor microenvironment responsive probe based on the long-lasting nanoparticles prepared in Example 1
[0073] (1) Synthesis of PLNP-pep:
[0074] The obtained PLNP-NH2 solid powder was ultrasonically dispersed in DMF, and the concentration of PLNP-NH2 was 2 mg mL -1 ; Add anhydrous K2CO3 until the solution becomes alkaline, then add bromoacetyl bromide, and stir the reaction at room temperature overnight in a sealed state. After the reaction is completed, the solid is collected by centrifugation, washed alternately with ethanol and purified water 4 times, and freeze-dried to obtain a brown-red solid powder PLNP-Br; Ultrasonic disperse PLNP-Br in DMF, add anhydrous K2CO3 until the solution becomes alkaline, then add TAT / PD-L1 polypeptide, and stir the reaction at room temperature overnight. After the reaction is completed, the solid is collected by centrifugation, washed alternately with ethanol and purified water 4 times, and freeze-dried to obtain PLNP-pep;
[0075] (2)PLNP-pep@Cu 2+ Synthesis of:
[0076] PLNP-pep solid was ultrasonically dispersed in anhydrous methanol, and CuCl2·2H2O (CuCl2·2H2O:PLNP-pep=17mg:10mg) was added and shaken at room temperature for 4 hours. After the reaction, PLNP-pep@Cu was washed once with ultrapure water to obtain 2 + ;
[0077] (3)PLNP-pep@Cu 2+ / RAW preparation:
[0078] To 10mL containing 10 5 Add 20 μL of LPS to the DmEm solution of macrophages / mL at a concentration of 1 mg mL -1 LPS was used for polarization, and the medium was changed every 24 hours for a total of 72 hours. The polarized M1 macrophages were then incubated with PLNP-pep@Cu 2+ The nanoparticles were dispersed together in PBS and incubated with ultrasound for 30 min. After continuous extrusion through a 1 μm polycarbonate filter membrane using a micro extruder, the individual nanomaterials were removed by centrifugation to obtain the PLNP-pep@Cu loaded material.2+ / RAW; the number of extrusions is 10.
[0079] Example 4:
[0080] The steps and methods are basically the same as those in Example 3, except that the number of extrusions in step (3) is changed to 8 times, and the other parts remain unchanged to obtain the corresponding material. Figure 5 (a is squeezed 10 times, b is squeezed 8 times) shows that when the number of squeezes is less than 10 times, the macrophage membrane cannot be wrapped.
[0081] Example 5:
[0082] PLNP-pep@Cu prepared in Example 3 2+ To explore the in vitro tumor microenvironment response performance:
[0083] The main research contents include the GSH response performance and chemodynamic therapeutic performance of the probe.
[0084] (1) GSH response performance:
[0085] Glutathione (reduced form) was selected to verify the PLNP-pep@Cu 2+ 2 mg of PLNP-pep@Cu 2+ Ultrasonic dispersion was performed in 2 mL of ultrapure water, and then glutathione was added to the above solution and incubated on a shaker at room temperature for 4 h.
[0086] like Figure 6 As shown, Cu 2+ The phosphorescence of PLNP-pep at 700nm can be completely quenched. After adding GSH, the phosphorescence at 700nm gradually recovered, and the recovered phosphorescence intensity was proportional to the amount of GSH added. 50mM GSH can make PLNP-pep@Cu 2+ The phosphorescence at 700 nm reaches its maximum recovery, which is because GSH can react with Cu 2+ reaction, resulting in the recovery of PLNP phosphorescence.
[0087] like Figure 7 As shown, PLNP-pep@Cu 2+ After reacting with glutathione, an obvious aggregation state was formed, and Figure 8 The hydrodynamic diameter is significantly increased. This phenomenon is due to the fact that GSH 2+The disulfide bond of PEP is cut, exposing one end of TAT with -S- residue to form PLNP-TAT-S-. PLNP-TAT-S- can connect with other free PLNP-TAT-S- through -SS-, thus forming self-assembly and transforming single particles into large clusters.
[0088] (2) Chemodynamic therapeutic properties:
[0089] Methylene blue (MB) was used as an indicator to investigate the 2+ CDT performance. The specific operation is: prepare 500mmol L -1 NaHCO3, 200 μg mL -1 MB and 200mmol L -1 H2O2, PLNP-pep@Cu 2+ Dispersed in PBS buffer at pH 6.0 to a concentration of 1 mg mL -1 Take 50μL of NaHCO3, MB and NaHCO3 in a centrifuge tube and add 150μL of PLNP-pep@Cu 2+ The solution was made up to 1 mL with water, and then the mixture was shaken at 37°C in the dark for 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, and 4.0 h. After the reaction, the mixture was centrifuged at 5000 rpm for 5 min, and the absorbance change of the supernatant at 664 nm was measured. 50 μL of NaHCO3, MB, and NaHCO3 were taken in centrifuge tubes, and 0 μL, 10 μL, 20 μL, 50 μL, 75 μL, 100 μL, 125 μL, and 150 μL of PLNP-pep@Cu were added respectively. 2+ The solution was made up to 1 mL with water. Then, the mixture was shaken at 37°C in the dark for 4 h. After the reaction, the mixture was centrifuged at 5000 rpm for 5 min. The change in absorbance of the supernatant at 664 nm was measured. 2+ chemical kinetic properties.
[0090] from Figure 9 It can be seen that the addition of PLNP-pep@Cu 2+ After the reaction, the absorbance of MB decreased significantly, which was time-dependent and concentration-dependent. 2+ Release of Cu 2+ , and catalyzes H2O2 to generate ·OH, so the probe has chemical kinetic properties.
[0091] Example 6:
[0092] PLNP-pep@Cu prepared in Example 3 2+ / RAW investigates microenvironmental response imaging and therapeutic performance at the cellular level:
[0093] The main research contents include PLNP-pep@Cu 2+ In vitro imaging, chemodynamic therapy effects, and cell killing mechanisms.
[0094] (1) Imaging performance at the cellular level: Mouse squamous cell carcinoma cell line (SCC-7) and mouse embryonic fibroblast cell line (3T3) were used as cell models to study the PLNP-pep@Cu 2+ / RAW in vitro imaging performance. The specific operation is to add 1mL10 5 cells mL -1 The cell suspension was added to the Confocal dish and cultured for 24 hours to allow the cells to adhere to the wall. Then, PLNP-TAT (the preparation method is the same as PLNP-pep, except that TAT is used instead of TAT-PD-L1), PLNP-pep, PLNP-pep@Cu 2+ / RAW (100 μg mL -1 ) was added to replace the original culture medium, and after culturing for 24 h, the cells were fixed with 4% paraformaldehyde at room temperature, and then DAPI dye was added, stained in the dark, and then imaged under a confocal laser scanning microscope (CLSM).
[0095] like Figure 10 As shown in the figure, PLNP-TAT can penetrate the 3T3 cell membrane and enter the cytoplasm after 1 hour of co-culture with 3T3 cells, and as the culture time increases, more PLNP-TAT has entered the 3T3 cells. However, PLNP-pep was not clearly observed in the cells until 6 hours of co-culture. 2+ / RAW particles can only be seen in 3T3 cells at 6 h. As the culture time increases, the PLNP-pep@Cu 2+ / RAW increases. This is because TAT can accelerate the speed of nanoparticles entering cells. In the normal cell environment, PLNP-pep@Cu 2+ / RAW light is always in a quenched state and is in a "turn-off" state even after being co-cultured with 3T3 cells for 24 hours.
[0096] like Figure 11As shown in the figure, PLNP-pep can be observed inside SCC-7 cells after culturing them for 2 hours. The speed at which PLNP-pep enters SCC-7 cells is significantly faster than that of 3T3 cells. In addition, a large amount of PLNP-pep can be clearly seen surrounding the cell nucleus after culturing for 4 hours, proving that PLNP-pep can indeed self-assemble in the tumor microenvironment. 2+ When PLNP-PEP@Cu / RAW was co-cultured with SCC-7 cells for 1 hour, it could be observed inside the cells and emitted weak luminescence. When the co-culture time reached 2 hours, PLNP-PEP@Cu 2+ / RAW phosphorescence recovery, and into SCC-7 cells, indicating that the modification of RAW can make PLNP-pep@Cu 2+ / RAW enters cells in a shorter time and indeed has "turn-on" imaging with targeted self-assembly in the tumor microenvironment.
[0097] (2) Chemodynamic therapy effects at the cellular level:
[0098] The PLNP-pep@Cu 2+ / RAW CDT killing effect at the cellular level. SCC-7 was diluted to a concentration of 1×10 5 cells mL -1 100 μL of cell suspension was added to the 96-well plate and cultured for 24 h. 2+ / RAW(50μg mL -1 , 100 μg mL -1 , 150 μg mL -1 , 250 μg mL -1 and 300 μg mL -1 ) were used to replace the original culture medium and H2O2 (100 μM) was added. The control group was added with equal amounts of materials without H2O2. Cells cultured in fresh DMEM medium without the probe served as blank control.
[0099] like Figure 12 、 13 As shown, PLNP-pep@Cu 2+ / RAW itself has a certain killing effect on SCC-7 cells, and the killing effect is concentration-dependent. However, when 100μM H2O2 is added, PLNP-pep@Cu 2+ / RAW has a more obvious killing effect, and PLNP-pep@Cu 2+ With the increase of RAW concentration, the cell survival rate decreased significantly. This result can indicate that PLNP-pep@Cu 2+ / Cu in RAW2+ It does have a chemodynamic therapeutic effect in the tumor microenvironment and is concentration-dependent.
[0100] (3) Cell killing mechanism:
[0101] DCFH-DA was used as an indicator to detect PLNP-pep@Cu 2+ / RAW singlet oxygen production in SCC-7 cells during treatment. DCFH-DA was diluted in serum-free DMEM to a final concentration of 10 μM. Materials were added to the culture medium. The first group did not add materials or H2O2; the second group only added PLNP-pep@Cu 2+ (300 μg mL -1 ); the third group only added PLNP-pep@Cu 2+ / RAW(300μg mL -1 ); the fourth group only added H2O2 (100μM); the fifth group added PLNP-pep@Cu 2+ (300 μg mL -1 ) and H2O2 (100μM); the sixth group added PLNP-pep@Cu 2+ / RAW(300μgmL -1 ) and H2O2 (100μM). The original SCC-7 culture medium was replaced with the above culture medium and cultured for 4h. After the culture was completed, CLSM imaging was performed.
[0102] Figure 14 Shown in PLNP-pep@Cu 2+ After co-incubation with RAW, only PLNP-pep@Cu 2+ PLNP-pep@Cu 2+ Obvious green fluorescence signals were detected in the cells of the / RAW group, while no green fluorescence was detected in the untreated SCC-7 cells, indicating that only Cu 2+ Only when hydroxybenzoate is present can ·OH be generated significantly, confirming the chemodynamic therapeutic mechanism.
[0103] The present invention prepares ultra-small-sized long-lasting-glow nanoparticles (ZnGa2O4:Cr-NH2, PLNP-NH2) based on a one-step method, and further modifies PLNP-NH2 by TAT / PD-L1, Cu 2+ The modification of RAW and the modification steps of RAW were further used to construct the tumor microenvironment responsive probe PLNP-pep@Cu 2+ / RAW; The method for preparing long-lasting glow nanomaterials of the present invention effectively simplifies the post-modification process. The obtained long-lasting glow nanomaterial particles are small in size, which effectively increases the metabolic time in the body and avoids their accumulation in the endothelial reticular system such as the liver; the prepared tumor microenvironment responsive probe PLNP-pep@Cu 2+ / RAW, quenching the long-lasting red phosphorescence, and when it reaches the tumor site, the overexpressed GSH converts Cu 2+ Reduction to Cu + , so that the red phosphorescence of the probe is restored and accurate imaging is achieved; and the prepared PLNP-pep@Cu 2+ / RAW self-aggregates, the particle size increases, and the retention time at the lesion site is increased, achieving better imaging effects; when reaching the tumor site, the released Cu + It can act as a chemokinetic catalyst, catalyzing the conversion of endogenous H2O2 into ·OH, exerting a chemokinetic therapeutic effect. This invention simplifies the post-modification process of long-lasting fluorescence nanoparticles; it combines the advantages of PLNPs, such as the lack of in-situ excitation and background fluorescence interference, the specific imaging of microenvironment-responsive probes, and the effective treatment of cancer, and has broad prospects in the field of cancer diagnosis and treatment.
[0104] Although the present invention has been disclosed above in terms of preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. One-step amino method for preparing ultra-small size long afterglow nanoparticles, It is characterized in that The steps include: S11, Zn(acac) 2 ·xH 2 O, Ga(acac) 3 、Cr(acac) 3 The solid is heated and dissolved in a mixed solution formed by octadecene and oleic acid, the mixture is cooled to 40-50°C, methanol and ethylenediamine are added, and stirring is maintained to obtain a mixed solution; the mixed solution is transferred to a high-pressure reactor for a solvent thermal reaction, and after the reaction is completed, it is cooled, ethanol is added to precipitate the product, the solid-liquid separation is performed, the solid is collected, washed, and dried to obtain ultra-small size long afterglow nanoparticles PLNP-NH 2 Solid powder.
2. The method for preparing ultra-small-sized long-afterglow nanoparticles by a one-step amino process according to claim 1, It is characterized in that In step S11, in the mixed solution formed by octadecene and oleic acid, the volume ratio of octadecene to oleic acid is 5:2-5:3; And / or, in step S11, the volume ratio of ethylenediamine to oleic acid is 1:1-1:
3.
3. The method for preparing ultra-small-sized long-afterglow nanoparticles by a one-step amino process according to claim 1, It is characterized in that In step S11, Zn(acac) 2 ·xH 2 O, Ga(acac) 3 、Cr(acac) 3 The molar ratio is 1:2:0.001-1:2:0.008; Zn(acac) 2 ·xH 2 The concentration of O in the mixed system is 0.005-0.05mmolmL -1 .
4. The method for preparing ultra-small-sized long-afterglow nanoparticles by a one-step amino process according to claim 1, It is characterized in that In step S11, the amount of methanol added is 5%-20% of the total volume; And / or, in step S11, the solvent thermal reaction is carried out at 180-250° C. for 24-72 hours.
5. A GSH-activated / induced aggregation ultra-small long afterglow probe PLNP-pep@Cu 2+ / RAW construction method, It is characterized in that Ultra-small size long afterglow nanoparticles PLNP-NH obtained by the preparation method according to any one of claims 1 to 4 2 ; The preparation method comprises the following steps: S12, modification of TAT / PD-L1 polypeptide chain: PLNP-NH 2 The solid powder was ultrasonically dispersed in DMF and anhydrous K 2 CO 3 Then, bromoacetyl bromide was added, and the reaction was stirred in a sealed state. After the reaction was completed, the solid powder PLNP-Br was obtained by washing and drying. PLNP-Br was dispersed in DMF and anhydrous K 2 CO 3 Then, TAT / PD-L1 peptide was added and stirred for reaction. After the reaction, PLNP-pep was obtained after washing and drying. S13, Cu 2+ Modification: The PLNP-pep solid prepared in step S12 was ultrasonically dispersed in anhydrous methanol and Cu 2+ , shake and react at room temperature, and wash to obtain PLNP-pep@Cu 2+ ; S14. Targeted modification of cell membrane RAW: LPS was added to the DMEM solution containing macrophages for polarization; the polarized M1 macrophages were mixed with PLNP-pep@Cu 2+ Dispersed in PBS, incubated with ultrasound, and continuously extruded through the filter membrane using a micro extruder to remove the individual nanomaterials, the loaded material PLNP-pep@Cu 2+ / RAW.
6. A GSH activated / induced aggregation ultra-small long afterglow probe PLNP-pep@Cu according to claim 5 2+ / RAW construction method, It is characterized in that In step S12, PLNP-NH 2 The concentration is 1-2mgmL -1 ; And / or, in step S12, K 2 CO 3 The dosage is based on ensuring that the reaction system becomes alkaline; And / or, in step S12, the concentration of PLNP-Br is 1-2 mg mL -1 ; And / or, in step S12, the TAT / PD-L1 polypeptide sequence is: RKKRRQRRRC&CVRARTR.
7. A GSH activated / induced aggregation ultra-small long afterglow probe PLNP-pep@Cu according to claim 5 2+ / RAW construction method, It is characterized in that In step S13, the concentration of PLNP-pep is 1-2 mg mL -1 ; And / or, in step S13, the CuCl 2 ·2H 2 The amount of O is 1.7-3.4 mg mL -1 .
8. A GSH activated / induced aggregation ultra-small long afterglow probe PLNP-pep@Cu according to claim 5 2+ / RAW construction method, It is characterized in that In step S14, the concentration of macrophages in the solution is not less than 10 5 Pieces / mL; And / or, in step S14, the number of extrusions is not less than 10 times.
9. The GSH activated / induced aggregation ultra-small long afterglow probe obtained by the construction method according to any one of claims 3 to 8, It is characterized in that Achieve tumor microenvironment-specific imaging and have chemodynamic therapeutic effects.
10. Use of the GSH activated / induced aggregation ultra-small long afterglow probe according to claim 9 in biological imaging preparations or in the preparation of anti-tumor drugs.
